We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Artificial Anti-Oxidant the Next “Go-To” Supplement?

News   Sep 12, 2018 | Original story by Nathan Skolski for the University of British Columbia

 
Artificial Anti-Oxidant the Next “Go-To” Supplement?

Gino DiLabio is a professor and head of the Department of Chemistry at UBC Okanagan. Credit: UBC Okanagan

 
 
 

RELATED ARTICLES

Existing Drug Could Treat Porphyria

News

An existing antifungal drug, ciclopirox (CPX), has been shown to improve symptoms associated with congenital erythropoietic porphyria – the rarest type of porphyria.

READ MORE

$3M Grant to Advance Drugs for ALS, Alzheimer's & Parkinson's

News

A new four-year, $3 million grant will enable Scripps Research scientists to advance compounds that may protect neurons in diseases caused by toxic protein accumulation, including Parkinson’s, ALS, Alzheimer’s and Creutzfeldt-Jakob disease.

READ MORE

A Way to Enhance Adsorption of Chemotherapy Drugs

News

A new study demonstrates adsorption of chemotherapy drugs onto active carbon delivery capsule can be enhanced with aluminium atom inclusions.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE